Last reviewed · How we verify
NCT04385901
Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth
NA trial testing Therapy Intervention in SARS-CoV 2 in 26 participants. Completed in 19 September 2020.
19 September 2020
Quick facts
| Lead sponsor | University of Missouri-Columbia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 19 May 2020 |
| Primary completion | 19 September 2020 |
| Estimated completion | 19 September 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Therapy Intervention
Conditions studied
- SARS-CoV 2 — all drugs for SARS-CoV 2 →
- SARS Pneumonia — all drugs for SARS Pneumonia →
Sponsor
University of Missouri-Columbia
Who can join
18 and older, any sex, with SARS-CoV 2 or SARS Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study seeks to assess the impact of physical and pulmonary rehabilitation on patients who have been diagnosed with COVID-19 in the short and long term in hopes of establishing a best practices protocol for treatment of future patients with this disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04385901
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SARS-CoV 2
Currently open trials in the same condition.
- NCT04853004 — Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations · active not recruiting
- NCT04568148 — COVID-19 Biorepository · active not recruiting
Other University of Missouri-Columbia trials
Trials by the same sponsor.
- NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
- NCT07385105 — Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI) · NA · not yet recruiting
- NCT07067502 — Impact of Biphasic Cuirass Ventilation Compared to Non Invasive Ventilation in High Risk Extubations · NA · not yet recruiting
- NCT07424079 — Metacognitive Strategy Training Intervention for Transition-Age Youth With Cerebral Palsy · NA · not yet recruiting
- NCT07216196 — The Feasibility of a Remote Problem-Solving Intervention for Autistic Adolescents or Young Adults and a Caregiver · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04385901 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Missouri-Columbia
- Last refreshed: 8 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04385901.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing